Richard Aldrich, Director at KalVista Pharmaceuticals, Inc. (KALV), bought 1,130,130 shares at $8.61 ($9.7M) on 2017-10-12, disclosed to the SEC on 2017-10-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.61 | 565,065 | $4.9M | 50.0% |
| 2 | $8.61 | 565,065 | $4.9M | 50.0% |
| Total | $8.61 avg | 1,130,130 | $9.7M | 100% |
| Filing → |
| CNCE | SELL | 2018-02-01 | $356K | — | Filing → |
| CNCE | SELL | 2018-01-29 | $434K | — | Filing → |
| CNCE | SELL | 2018-01-24 | $689K | — | Filing → |